No products in the cart.
Description
PRODUCT DESCRIPTION:
Mesna (2-mercaptoethane sulfonate sodium) is a critical uroprotective agent used to prevent hemorrhagic cystitis caused by oxazaphosphorine chemotherapy agents such as ifosfamide and cyclophosphamide.
It works by detoxifying urotoxic metabolites like acrolein in the urinary tract.
This ready-to-administer pre-filled syringe presentation ensures precision, compliance, and convenience in oncology settings where time-sensitive chemotherapy support is critical.
Formulation & Presentation:
- Dosage Form: Sterile Injectable
- Presentation: Both in Lyophilized & Pre-Filled Syringe (customizable as per market demand)
- Available Strengths:
- 200 MG/ 2 ML
- 400 MG/ 4 ML
- Route of Administration: Intravenous (IV) Bolus or after appropriate reconstitution or as per clinical indication and severity. Reconstituted as per protocol Intravenous infusion. To be administered under supervision of a qualified oncologist or day-care oncology units. (As per physician’s discretion or decision) Administered as continuous infusion, typically as part of combination chemotherapy regimens
Therapeutic Indications:
- Prevention of hemorrhagic cystitis during chemotherapy with Ifosfamide or Cyclophosphamide
- Supportive care in pediatric and adult oncology protocols
Side Effects:
- COMMON:
- Nausea
- Vomiting
- Headache
- Fatigue
- Injection site reactions
- SERIOUS (RARE):
- Hypersensitivity or anaphylactic reactions
- Hypotension
- Rash or urticaria
- Flushing or dizziness
- PRECAUTIONS:
- Monitor patients for signs of allergic reactions, especially during initial use
- Do not substitute Mesna orally unless clearly indicated, due to altered bioavailability
- Ensure synchronized administration with oxazaphosphorine dosing schedules
- Use with caution in patients with sulfur allergies
Be the first to review “Mesna Injection 200 MG/2 ML, 400 MG/4 ML Pre-Filled Syringe”
TECHNICAL INFORMATION
Product Specifications
- HSN Code: To be assigned per international classification standards & import jurisdiction
- Weight: Approx. 40g per Carton (With Packaging)
- Dimensions: 15 x 1 x 8 CMS
- Shelf Life: 24 to 36 months under recommended storage conditions from date of manufacture or as per label specifications
- Storage:
- Pre-Filled Syringes: Store below 2°C–8°C
- Lyophilized Injection: Store below 25°C
- Do not freeze. Requires cold-chain logistics. Protect from moisture and direct sunlight. Use strictly as per label guidelines.
Regulatory Status & Supply Information
- Regulatory Status: WHO-GMP Compliant Manufacturing. COA, MSDS, Stability Data, Batch Record & Dossier Support available on request
- Export Dossiers: Available in CTD/eCTD formats
- Stability: Compliant
- MOQ: Negotiable based on market & registration status
- Export Options: Available for private label, institutional supply, or branded export
Who Should Source This Product?
- Government oncology departments implementing chemoprotection protocols
- Hospital procurement teams managing chemotherapy units
- Importers/distributors of high-risk chemotherapy adjuvants
- NGOs and humanitarian bodies supporting cancer treatment safety
- Oncology centers in LATAM, Africa, and South Asia minimizing urological complications
Why Source from PHARMET?
- Single-window sourcing for diverse pharma needs
- Export-ready documentation & regulatory support
- Adaptable documentation for effective international registration
- Trusted consortium simplifying India’s complex pharma supply chain
- Multiple approved manufacturers for country-specific fit
- Audited, compliant manufacturer network across India
- Flexible branding, packaging, and formulation options
- End-to-end logistics and cold-chain support
- Specialized expertise in exporting chemoprotectives and oncology injectables
Contact Details
- Email: hello@pharmet.io
- Phone/WhatsApp: +91 9999091881
- Website: www.pharmet.io
Reviews
There are no reviews yet.